These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 1693245
1. The significance of carbohydrate trimming for the antigenicity of the Semliki Forest virus glycoprotein E2. Kaluza G, Repges S, McDowell W. Virology; 1990 Jun; 176(2):369-78. PubMed ID: 1693245 [Abstract] [Full Text] [Related]
6. Semliki Forest virus E2 envelope epitopes induce a nonneutralizing humoral response which protects mice against lethal challenge. Grosfeld H, Velan B, Leitner M, Cohen S, Lustig S, Lachmi BE, Shafferman A. J Virol; 1989 Aug; 63(8):3416-22. PubMed ID: 2473217 [Abstract] [Full Text] [Related]
7. Investigation of the role of glycans for the biological activity of Semliki Forest virus grown in Aedes albopictus cells using inhibitors of asparagine-linked oligosaccharides trimming. Naim HY, Koblet H. Arch Virol; 1988 Aug; 102(1-2):73-89. PubMed ID: 2973779 [Abstract] [Full Text] [Related]
8. Identification of distinct antigenic determinants on Semliki Forest virus by using monoclonal antibodies with different antiviral activities. Boere WA, Harmsen T, Vinjé J, Benaissa-Trouw BJ, Kraaijeveld CA, Snippe H. J Virol; 1984 Nov; 52(2):575-82. PubMed ID: 6208379 [Abstract] [Full Text] [Related]
9. Processing of gPr92env, the precursor to the glycoproteins of Rous sarcoma virus: use of inhibitors of oligosaccharide trimming and glycoprotein transport. Bosch JV, Schwarz RT. Virology; 1984 Jan 15; 132(1):95-109. PubMed ID: 6320537 [Abstract] [Full Text] [Related]
10. Novel mannosidase inhibitor blocking conversion of high mannose to complex oligosaccharides. Fuhrmann U, Bause E, Legler G, Ploegh H. Nature; 1984 Jan 15; 307(5953):755-8. PubMed ID: 6230538 [Abstract] [Full Text] [Related]
11. Identification of linear epitopes on Semliki Forest virus E2 membrane protein and their effectiveness as a synthetic peptide vaccine. Snijders A, Benaissa-Trouw BJ, Oosterlaken TA, Puijk WC, Posthumus WP, Meloen RH, Boere WA, Oosting JD, Kraaijeveld CA, Snippe H. J Gen Virol; 1991 Mar 15; 72 ( Pt 3)():557-65. PubMed ID: 1706409 [Abstract] [Full Text] [Related]
12. Neutralization epitope of varicella zoster virus on native viral glycoprotein gp118 (VZV glycoprotein gpIII). Montalvo EA, Grose C. Virology; 1986 Mar 15; 149(2):230-41. PubMed ID: 2418586 [Abstract] [Full Text] [Related]
14. Discrimination of the determinant specificity of two competitive Semliki Forest virus neutralizing monoclonal antibodies by anti-idiotypic antibodies. Oosterlaken TA, Kraaijeveld CA, Snijders A, Harmsen M, Benaissa-Trouw BJ, Snippe H. Arch Virol; 1988 Mar 15; 100(1-2):115-20. PubMed ID: 2455492 [Abstract] [Full Text] [Related]
15. Neutralizing and non-neutralizing monoclonal antibodies to the E2 glycoprotein of Semliki Forest virus can protect mice from lethal encephalitis. Boere WA, Benaissa-Trouw BJ, Harmsen M, Kraaijeveld CA, Snippe H. J Gen Virol; 1983 Jun 15; 64 (Pt 6)():1405-8. PubMed ID: 6854274 [Abstract] [Full Text] [Related]
16. The mannosidase inhibitors 1-deoxymannojirimycin and swainsonine have no effect on the biosynthesis and infectivity of Rous sarcoma virus. Bosch JV, Tlusty A, McDowell W, Legler G, Schwarz RT. Virology; 1985 May 15; 143(1):342-6. PubMed ID: 2998010 [Abstract] [Full Text] [Related]